Summary
Alnylam Pharmaceuticals, Inc. (ALNY) filed an 8-K on February 11, 2021, to announce its financial results for the fourth quarter and full year ended December 31, 2020. While the filing itself is brief, it directs investors to a furnished press release (Exhibit 99.1) for the detailed financial and operational outcomes. Investors should carefully review this press release for comprehensive information regarding the company's performance, including revenue figures, earnings per share, and any forward-looking statements or strategic updates provided by management.
Key Highlights
- 1Announcement of Q4 and Full Year 2020 financial results.
- 2Filing includes a press release (Exhibit 99.1) containing detailed financial information.
- 3Information is furnished, not filed, meaning it is not subject to the liabilities of Section 18 of the Exchange Act unless expressly incorporated.
- 4Investors are directed to the press release for operational and financial condition updates.
- 5The filing's primary purpose is to disseminate the company's latest financial performance data.
Frequently Asked Questions
The main purpose of this 8-K filing is to publicly announce Alnylam Pharmaceuticals' financial results for the fourth quarter and the full year ended December 31, 2020, and to furnish the associated press release which contains these details.
The detailed financial results and operational highlights are located in the press release furnished as Exhibit 99.1 to this 8-K filing.
No, the information provided in Item 2.02 of this Form 8-K, including the furnished press release, is specifically stated as not deemed 'filed' for the purposes of Section 18 of the Exchange Act. It is furnished, not filed, unless the company expressly incorporates it by reference into another filing.
Investors should look for key metrics such as revenue growth, earnings per share (EPS) for the quarter and full year, net income/loss, cash and cash equivalents, and any commentary on sales performance of their key products. Forward-looking guidance or updates on pipeline development may also be included in the press release.